Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer
32970.0000 125.00 (0.38%)
NSE Aug 11, 2025 13:31 PM
Volume: 2,130
 

32970.00
0.38%
ICICI Securities Limited
Abbott India’s (Abbott) revenue grew 12% YoY ahead of most MNCs (avg. growth of ~10% YoY and IPM growth of ~8% YoY in Q4FY25). Abbott’s growth was aided by healthy traction in its own brands along with key brands of Novo Nordisk like Rybelsus and Ryzodeg.
Abbott India Ltd. has an average target of 35626.00 from 3 brokers.
More from Abbott India Ltd.
Recommended